Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma
- Po-Hao Feng
- , Kuan-Yuan Chen
- , Yu-Chen Huang
- , Ching-Shan Luo
- , Shen Ming Wu
- , Tzu-Tao Chen
- , Chun-Nin Lee
- , Chi-Tai Yeh
- , Hsiao-Chi Chuang
- , Chia-Li Han
- , Chiou-Feng Lin
- , Wei-Hwa Lee
- , Chih-Hsi Kuo
- , Kang-Yun Lee
- Taipei Medical University Shuang Ho Hospital
- Division of Pulmonary Medicine
- Graduate Institute of Clinical Medicine
- School of Respiratory Therapy
- Master Program in Clinical Genomics and Proteomics
- Department of Microbiology and Immunology
- TMU Research Center of Artificial Intelligence in Medicine and Health
- International Master Program in Medicine
- TMU Research Center of Biomedical Devices
- TMU Research Center of Cell Therapy and Regeneration Medicine
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- TMU Research Center of Cancer Translational Medicine
- TMU Research Center of Thoracic Medicine
- TMU Research Center of Neuroscience
- TMU Research Center of Urology and Kidney
- International Ph.D. Program for Translational Science
- The Ph.D. Program for Translational Medicine
- Ph.D. Program in Drug Discovery and Development Industry
- Department of Internal Medicine
- International Ph.D. Program in Medicine
Research output: Contribution to journal › Article › peer-review
73
Link opens in a new tab
Citations
(Scopus)